Liang Song
Directeur Général chez Insight Lifetech Co., Ltd.
Profil
Liang Song is the founder of Insight Lifetech Co., Ltd., a company founded in 2015.
He currently holds the titles of Chairman, CEO & General Manager at Insight Lifetech Co., Ltd.
Prior to founding Insight Lifetech Co., Ltd., Dr. Song worked as the Director-Laboratory for Biomedical Optics at The Shenzhen Institutes of Advanced Technology from 2012 to 2016.
Dr. Song obtained a doctorate degree from Washington University in St. Louis in 2010.
He also holds an undergraduate degree from Wuhan University, which he received in 2003, and a graduate degree from The Chinese University of Hong Kong, which he obtained in 2006.
Postes actifs de Liang Song
Sociétés | Poste | Début |
---|---|---|
Insight Lifetech Co., Ltd.
Insight Lifetech Co., Ltd. Medical SpecialtiesHealth Technology Insight Lifetech Co., Ltd. engages in the manufacture and sale of interventional cardiovascular diagnostic and therapy products. It offers exchange fractional flow reserve (FFR) microcatheters, cardiovascular pressure measurement (CPM) systems, intravascular ultrasound systems, and microcatheters for complex percutaneous coronary intervention (PCI). The company was founded by Xiao Yang Fu and Li Li Chen on December 11, 2015 and is headquartered in Shenzhen, China. | Directeur Général | 11/12/2015 |
Anciens postes connus de Liang Song
Sociétés | Poste | Fin |
---|---|---|
The Shenzhen Institutes of Advanced Technology | Corporate Officer/Principal | 01/03/2016 |
Formation de Liang Song
Wuhan University | Undergraduate Degree |
The Chinese University of Hong Kong | Graduate Degree |
Washington University in St. Louis | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Insight Lifetech Co., Ltd.
Insight Lifetech Co., Ltd. Medical SpecialtiesHealth Technology Insight Lifetech Co., Ltd. engages in the manufacture and sale of interventional cardiovascular diagnostic and therapy products. It offers exchange fractional flow reserve (FFR) microcatheters, cardiovascular pressure measurement (CPM) systems, intravascular ultrasound systems, and microcatheters for complex percutaneous coronary intervention (PCI). The company was founded by Xiao Yang Fu and Li Li Chen on December 11, 2015 and is headquartered in Shenzhen, China. | Health Technology |